172.57
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché THC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$178.50
Aprire:
$179.57
Volume 24 ore:
2.60M
Relative Volume:
1.84
Capitalizzazione di mercato:
$14.86B
Reddito:
$21.46B
Utile/perdita netta:
$2.65B
Rapporto P/E:
8.9734
EPS:
19.2312
Flusso di cassa netto:
$3.35B
1 W Prestazione:
-0.35%
1M Prestazione:
-10.33%
6M Prestazione:
-11.22%
1 anno Prestazione:
+2.98%
Tenet Healthcare Corp Stock (THC) Company Profile
Nome
Tenet Healthcare Corp
Settore
Industria
Telefono
469-893-2200
Indirizzo
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, DVA, FMS, EHC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
THC
Tenet Healthcare Corp
|
172.57 | 14.86B | 21.46B | 2.65B | 3.35B | 19.23 |
|
HCA
Hca Healthcare Inc
|
375.17 | 83.23B | 76.39B | 7.81B | 7.93B | 29.08 |
|
DVA
Davita Inc
|
207.91 | 13.34B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.59 | 12.67B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
98.03 | 9.72B | 6.07B | 793.80M | 464.40M | 5.9914 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Ripresa | Goldman | Buy |
| 2025-07-28 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-05-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Iniziato | Morgan Stanley | Overweight |
| 2025-02-26 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-12-16 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-27 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Iniziato | JP Morgan | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-03-29 | Iniziato | Wells Fargo | Overweight |
| 2022-02-10 | Aggiornamento | UBS | Neutral → Buy |
| 2022-02-09 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Aggiornamento | Truist | Hold → Buy |
| 2022-01-20 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Ripresa | Citigroup | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-09-24 | Iniziato | UBS | Neutral |
| 2021-08-12 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Ripresa | Citigroup | Buy |
| 2021-07-09 | Iniziato | Seaport Global Securities | Buy |
| 2021-05-03 | Ripresa | Goldman | Buy |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-15 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Aggiornamento | UBS | Neutral → Buy |
| 2019-11-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Ripresa | Goldman | Neutral |
| 2019-02-26 | Reiterato | BofA/Merrill | Neutral |
| 2019-01-14 | Iniziato | Stephens | Equal-Weight |
| 2019-01-03 | Iniziato | Deutsche Bank | Hold |
| 2018-12-17 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Iniziato | UBS | Neutral |
| 2018-06-29 | Downgrade | Jefferies | Buy → Hold |
| 2018-03-23 | Ripresa | Mizuho | Buy |
| 2018-01-30 | Ripresa | Wells Fargo | Market Perform |
| 2018-01-03 | Iniziato | Goldman | Neutral |
| 2017-12-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Reiterato | Mizuho | Neutral |
| 2017-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Tenet Healthcare Corp Borsa (THC) Ultime notizie
Why Tenet’s My Health Rec quietly matters for everyday patients - AD HOC NEWS
Tenet Healthcare Corp (THC) Shares Fall 3.3% -- What GF Score of 80 Tells Investors - GuruFocus
HCA Healthcare Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Judge denies Leapfrog Group’s appeal of Tenet lawsuit ruling - Modern Healthcare News
Tenet (THC) Upgraded to Buy: Here's Why - Yahoo Finance Singapore
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Tenet Healthcare Corp (THC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
BofA Maintains Buy Rating on Tenet Healthcare (THC) - Insider Monkey
Tenet Healthcare Corp (THC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tenet Healthcare Corp (THC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Tenet Healthcare Corp (THC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tenet Healthcare (THC) Laps the Stock Market: Here's Why - Yahoo Finance
HCA Healthcare Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Why Tenet Healthcare (THC) is a top value stock for the long term - MSN
HCA Healthcare Inc. stock rises Thursday, still underperforms market - MarketWatch
Hospital Rating Group Calls $10.5M Fee Bid 'Unreasonable' - Law360
THC Technical Analysis & Stock Price Forecast - Intellectia AI
HCA Healthcare Inc. stock underperforms Monday when compared to competitors - MarketWatch
Did Moody’s Credit Upgrade Just Reframe Tenet Healthcare’s (THC) Deleveraging Story for Investors? - Yahoo Finance
Jefferies recaps meetings with Healthcare Services companies - Investing.com
ETFs Investing in Tenet Healthcare Corporation Stocks - TradingView
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Tenet Healthcare (THC) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Moody’s upgrades Tenet Healthcare rating on deleveraging By Investing.com - Investing.com Canada
Moody’s upgrades Tenet Healthcare rating on deleveraging - Investing.com
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
HCA Healthcare Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is Tenet Healthcare Corp (THC) a Bargain After 3.8% Drop? GF Val - GuruFocus
Is Tenet Healthcare Corp (THC) a Bargain After 3.8% Drop? GF Value Says Undervalued - GuruFocus
Tenet Healthcare Corp (THC) Stock Price, Trades & News - GuruFocus
Tenet Healthcare Corp stock (US88033G4073): shares at fresh 20-day low as investors reassess hospita - AD HOC NEWS
Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit - Yahoo Finance
Tenet Healthcare Corp (THC) Stock Analysis: A 39.5% Upside Potential Amidst Robust Analyst Ratings - DirectorsTalk Interviews
Insider Selling Alert: J Kerrey Sells Shares of Tenet Healthcare Corp (THC) - GuruFocus
Tenet Healthcare Q1 2026 Earnings: Strong EPS Beat Fuels Positive Stock ReactionEarnings Surprise Score - newsline.com
Tenet Healthcare director J. Robert Kerrey sells $983,920 stock By Investing.com - Investing.com Australia
Tenet Healthcare director J. Robert Kerrey sells $983,920 stock - Investing.com
Tenet Healthcare (THC) director sells 5,638 shares, retains 16,804 - Stock Titan
Tenet Healthcare (THC) shareholders back board, pay plan and auditor at 2026 meeting - Stock Titan
Insider Sell: Nadja West Sells 3,000 Shares of Tenet Healthcare Corp (THC) - GuruFocus
Tenet Healthcare (THC) director awarded 1,188 restricted stock units as equity pay - Stock Titan
Tenet Healthcare (NYSE: THC) director awarded 1,188 restricted stock units - Stock Titan
Tenet Healthcare (THC) director receives 1,188 RSUs equity grant - Stock Titan
Tenet Healthcare Corp (THC) Shares Fall 4.3% -- What GF Score of 80 Tells Investors - GuruFocus
Fidelity submits Form 144 for THC restricted shares (NYSE: THC) - Stock Titan
[144] TENET HEALTHCARE CORP SEC Filing - Stock Titan
Tenet (NYSE: THC) director settles RSUs, returns shares to company - Stock Titan
Tenet Healthcare (THC) director converts 1,333 RSUs, boosting holdings to 4,446 shares - Stock Titan
Tenet Healthcare (THC) director exercises 1,333 RSUs into common shares, now holding 36,604 - Stock Titan
Tenet Healthcare Corp Azioni (THC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):